A revolutionary study by Case Western Reserve University researchers reveals that a class of medications used to treat type 2 diabetes may also lower the risk of colorectal cancer (CRC).
Ad Blocker Enabled!
Ad Blocker Enabled!
Our website is made possible by displaying online advertisements to our visitors. Please support us by disabling your Ad Blocker.